“I was continuously impressed by Jason's ability to innovate, adapt, and execute under pressure. We dealt with a ton of change during Jason's tenure, and despite the environmental challenges, Jason still was able to deliver high quality output across the board. That said, it is his ability to provide strategic insights that really sets him apart. Jason is someone you want on your team. ”
About
In an era where biology, tech, and business intersect, I offer a unique blend of…
Contributions
-
How do you measure and communicate the impact of your biotech solution?
Communicating impact can be challenging when narrative building is underutilized. Startups often present highly technical talks making it difficult for customers, employees, and investors to fully grasp the impact. A compelling narrative that resonates and is understandable is crucial. Large corporates tend to rely on marketing for storytelling, but every function can benefit. Take Medtronic Diabetes who effectively communicated the mission to build the artificial pancreas from the CEO to the line worker. It was motivating and created champions outside of traditional channels. To effectively communicate impact, tailor your message to the audience, build inspiring stories that connect, and remember that narratives are tools for everyone.
Activity
-
Just a delight to share my friend Mike Maples, Jr, with Arena Hall. He's one of the most successful venture investors, a brilliant thinker, and -…
Just a delight to share my friend Mike Maples, Jr, with Arena Hall. He's one of the most successful venture investors, a brilliant thinker, and -…
Liked by Jason Scharf
-
Pam and Chris Andrews joined Jason Scharf's podcast, Austin Next, to chat about Firefly Fund, our hopes for the #CenterforRareDisease at the Dell…
Pam and Chris Andrews joined Jason Scharf's podcast, Austin Next, to chat about Firefly Fund, our hopes for the #CenterforRareDisease at the Dell…
Liked by Jason Scharf
Experience
-
Early Stage Investor
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Publications
Recommendations received
6 people have recommended Jason
Join now to viewMore activity by Jason
-
This is such exciting news for Austin and the entire CPG world! At SKU, I feel so lucky to be working with emerging brands! It's such an energizing…
This is such exciting news for Austin and the entire CPG world! At SKU, I feel so lucky to be working with emerging brands! It's such an energizing…
Liked by Jason Scharf
Other similar profiles
Explore more posts
-
Carl Schoellhammer
Investment, therapeutic viability, and next-gen. technologies... That's what the cell therapy field needs. I had the pleasure of sitting down with Jason C. Foster of Ori Biotech recently on their podcast to talk all things cell therapy, the enabling technologies that support this modality, and the need for more investment. What did we touch on (and link to full podcast below)? Investors needing to see a return when investing in cell therapies. Need to bring manufacturing costs down to expand access. Next-gen. tools to create better, more robust therapies. Purpose-built therapies require purpose-built tools! Our consulting practice, how we help our clients, and how we view the field of advanced therapies. We take a differentiated approach to tracking, following, and mapping key trends across advanced therapies to bring novel, business-impacting insights to our clients. Want to discuss any of the above? Where the field of cell therapies are going? What it means for your own development pipeline? Reach out and let me know what you think in the comments! #celltherapy #venturecapital #consulting https://lnkd.in/g7SH9FAU
3 Comments -
Sally Ann Frank
📣 #Healthcare and #LifeSciences #startups: there's a new #VC #fund from Regeneron, led by Michael Aberman and Jay Markowitz. From the article: "Our goal is to cultivate an ecosystem where the next generation of #biotech companies can thrive, drawing on the lessons learned and successes achieved at Regeneron and throughout our careers,”Michael Aberman said in the release. “Together, we will strive to identify and support groundbreaking advancements that push the boundaries of what's possible in #science and #medicine.” Andrew Hwang Dylan Ozyjowski Ramesh Sethuraman
-
Marian Nakada, Ph.D.
Squire Servance founded Syridex Bio, a #healthequity VC fund that invests in therapeutics that address health disparities to drive positive social change. Check out this excellent podcast hosted by Christian Soschner to learn more! 🚀 Investing with Impact: Squire Servance on Health Equity & Venture Capital - proving that profitability and purpose can coexist. 🎙️ What's in the Episode: 1️⃣ Investing in Overlooked Markets: Learn how health disparities create massive untapped opportunities for innovation and investment. 2️⃣ The Power of Diversity: Squire Servance explains why investing in diverse founders and solutions yields better outcomes for both society and investors. 3️⃣ Data-Driven Impact: Discover how Servance evaluates companies to ensure they drive both health equity progress and financial returns. 📌 Quotes: (00:08:10) "The love just kind of grew, grew from there." (00:39:02) "Accelerating health equity, while generating returns, transforms lives and society." (00:57:45) "You can do good and do well by directing capitalism towards health equity." (01:17:35) "We're leaving money on the table by not investing in diverse founders." (01:25:46) "Everyone has blind spots; that's why diverse teams perform better." (01:45:29) "There's no shortcut for success."
6 Comments -
Damir Ibrahimagic Kopinic
🔬💰 Regeneron Ventures: Pioneering the Future of Biotech Investment 💰🔬 Exciting news from Regeneron as it launches Regeneron Ventures, its new private financing arm, with a whopping $500 million commitment over the next five years! Led by industry veterans Jay Markowitz, M.D., and Michael Aberman, M.D., this venture aims to revolutionize the biotech investment landscape. 🚀 🔍Regeneron Ventures is set to be agnostic to therapeutic area, technology, and stage of development, encompassing a wide array of companies beyond drug development, including devices, tools, and enabling technologies. With a bold vision to cultivate an ecosystem where the next generation of biotech companies can thrive, the team brings a wealth of expertise and experience from their tenure at Regeneron and beyond. 💡🌱 Markowitz joins from ARCH Venture Partners, where he was a senior partner and helped launch three companies, emphasizing, "We tolerate risk and uncertainty. We are open-minded. We doubt and question," reflecting the team's ethos of innovation and exploration. 🤝Aberman, with his background as the senior vice president of investor relations and strategy at Regeneron, echoes the sentiment, stating, "Our goal is to cultivate an ecosystem where the next generation of biotech companies can thrive, drawing on the lessons learned and successes achieved at Regeneron and throughout our careers." Regeneron Ventures joins the ranks of leading pharmaceutical companies with venture capital arms, positioning itself to play a pivotal role in shaping the future of healthcare innovation. With a commitment to embracing risk and uncertainty, the venture is primed to identify and support transformative opportunities that have the potential to revolutionize the industry. 💪🌐 In a landscape where innovation is key, Regeneron Ventures stands at the forefront, ready to champion the next wave of biotech breakthroughs. With its unwavering dedication to fostering innovation and pushing the boundaries of scientific discovery, Regeneron Ventures is set to make a lasting impact on the world of biotech investment. 🌎💼 ✅ Looking to raise capital for your #fund and increase the international pool of your LP #investors? 🤝 Need warm #LP introductions? 📝 Selling #secondaries to increase liquidity? 🧐 Looking for co-investments? ▶ G QUANT's link for inquiries and fund decks: https://lnkd.in/gjC_EuTE #RegeneronVentures #BiotechInvestment #Innovation #Healthcare #VentureCapital #BiotechRevolution #FutureofMedicine
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Jason Scharf in United States
-
Jason Scharf
Data Program Manager | Web Development Instructor
-
Jason Scharf
Director of Application Development
-
Jason Scharf
-
Jason Scharf
Founding Partner at Ghost Experiential, LLC
18 others named Jason Scharf in United States are on LinkedIn
See others named Jason Scharf